While ERα promotes proliferation and inflammation of prostate cancer cells, driving disease progression even after ADT, ERβ generally exhibits antiproliferative and pro-apoptotic effects that suppress tumor growth [38]. This evidence concerns the gene ESR1 and prostate carcinoma.